Meag Munich Ergo’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.1M | Buy |
+54,104
| New | +$24.1M | 0.68% | 51 |
|
|
2023
Q2 | – | Sell |
-3,448
| Closed | -$1.09M | – | 204 |
|
|
2023
Q1 | $1.09M | Sell |
3,448
-4,202
| -55% | -$1.32M | 0.05% | 124 |
|
|
2022
Q4 | $2.21M | Sell |
7,650
-3,225
| -30% | -$931K | 0.12% | 106 |
|
|
2022
Q3 | $3.15M | Buy |
10,875
+8,760
| +414% | +$2.54M | 0.19% | 89 |
|
|
2022
Q2 | $596K | Buy |
2,115
+455
| +27% | +$128K | 0.04% | 169 |
|
|
2022
Q1 | $439K | Buy |
+1,660
| New | +$439K | 0.03% | 174 |
|
|
2021
Q4 | – | Sell |
-7,177
| Closed | -$1.3M | – | 243 |
|
|
2021
Q3 | $1.3M | Hold |
7,177
| – | – | 0.23% | 92 |
|
|
2021
Q2 | $1.45M | Sell |
7,177
-296
| -4% | -$59.7K | 0.14% | 150 |
|
|
2021
Q1 | $1.61M | Buy |
7,473
+2,658
| +55% | +$571K | 0.16% | 136 |
|
|
2020
Q4 | $1.12M | Buy |
+4,815
| New | +$1.12M | 0.26% | 112 |
|
|
2020
Q3 | – | Sell |
-5,767
| Closed | -$1.67M | – | 231 |
|
|
2020
Q2 | $1.67M | Buy |
+5,767
| New | +$1.67M | 0.31% | 86 |
|
|
2020
Q1 | – | Sell |
-3,960
| Closed | -$867K | – | 484 |
|
|
2019
Q4 | $867K | Sell |
3,960
-12,895
| -77% | -$2.82M | 0.09% | 209 |
|
|
2019
Q3 | $2.8M | Buy |
16,855
+5,402
| +47% | +$897K | 0.14% | 163 |
|
|
2019
Q2 | $2.05M | Sell |
11,453
-1,018
| -8% | -$182K | 0.16% | 143 |
|
|
2019
Q1 | $2.27M | Buy |
12,471
+9,571
| +330% | +$1.75M | 0.19% | 122 |
|
|
2018
Q4 | $472K | Hold |
2,900
| – | – | 0.06% | 288 |
|
|
2018
Q3 | $547K | Hold |
2,900
| – | – | 0.03% | 341 |
|
|
2018
Q2 | $432K | Hold |
2,900
| – | – | 0.03% | 338 |
|
|
2018
Q1 | $461K | Sell |
2,900
-25,647
| -90% | -$4.08M | 0.02% | 361 |
|
|
2017
Q4 | $4.34M | Buy |
+28,547
| New | +$4.34M | 0.17% | 162 |
|